Gilead Sciences | 66.7000 / -2.14% |
Date/Time | 01/26 / 22:00 |
Chg. / Chg.(%) | -1.4600 / -2.14% |
Bid | 66.3600 / 600 |
Ask | 66.4500 / 100 |
Open | 67.7200 |
Previous Close | 68.1600 |
High | 68.3800 |
Low | 66.5600 |
Volume [USD] | 384,756,821.3493 |
Volume [Units] | 7,125,214 |
Price fixings | 28682 |
ISIN | US3755581036 |
Security | GILD |
Exchange | NASDAQ |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
NASDAQ | 66.7000 | ![]() |
7,125,214 |
Cboe US | 66.69 | ![]() |
561,682 |
IEX | 66.70 | ![]() |
352,106 |
TradeGate | 55.100 | ![]() |
16,942 |
Xetra | 55.21 | ![]() |
16,730 |
London Inter.. | 67.69 | ![]() |
6,663 |
Frankfurt | 55.0000 | ![]() |
2,301 |
Stuttgart | 54.810 | ![]() |
1,367 |
Borsa Italia.. | 55.33 | ![]() |
1,151 |
Vienna Globa.. | 55.30 | ![]() |
1,075 |
gettex | 54.970 | ![]() |
948 |
München | 55.99 | ![]() |
190 |
Mexico | 1,333.00 | ![]() |
146 |
Borsa Italia.. | 54.71 | ![]() |
20 |
Berlin | 55.84 | ![]() |
0 |
Hannover | 55.87 | ![]() |
0 |
Düsseldorf | 54.78 | ![]() |
0 |
Hamburg | 55.87 | ![]() |
0 |
Lang & Schwa.. | 54.670 | ![]() |
News
- NICE recommends Jyseleca® ▼(filgotinib) on NHS in landmark decision for rheumatoid arthritis
01/21/2021 / 08:08 - GlobeNewswire - Jounce Therapeutics Announces Initiation of Phase 1 INNATE Study of JTX-8064 (LILRB2/ILT4 Inhibitor) Monotherapy and PD-1 Inhibitor Combination Therapy in Patients with Advanced Solid Tumors
01/13/2021 / 14:00 - GlobeNewswire - Gilead holds 25.54% of Galapagos shares
01/11/2021 / 22:01 - GlobeNewswire - Remdesivir could work against new COVID strains - Gilead
01/11/2021 / 15:21 - TeleTrader - Intercept Appoints Jared M. Freedberg as General Counsel and Secretary
01/11/2021 / 14:00 - GlobeNewswire